Mounjaro (Tirzepatide) Injection 5 mg/0.5 mL Prefilled Syringes (4-Pack) **Refrigeration Required (RX)

Mounjaro (Tirzepatide) Injection is a medication used to treat adults with type 2 diabetes. It is a prefilled syringe that contains 5 mg of tirzepatide in 0.5 mL of solution. The syringes come in a pack of 4 and are intended for subcutaneous (under the skin) injection. Tirzepatide belongs to a class of medications called GLP-1 receptor agonists, which work by helping the body produce more insulin and reducing sugar production in the liver. It also helps with weight management by promoting feelings of fullness and reducing food intake. Mounjaro injections are typically used in combination with a healthy diet and exercise to help control blood sugar levels in individuals with type 2 diabetes.

Mounjaro (Tirzepatide) is a type of medication called a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is used to help improve blood sugar control in adults with type 2 diabetes.

Tirzepatide works by mimicking the action of two naturally occurring hormones in the body, GIP and GLP-1. Both of these hormones are involved in regulating blood sugar levels.

GLP-1 helps to increase insulin production and release from the pancreas, while decreasing the production of glucagon, a hormone that raises blood sugar levels. GIP also stimulates insulin production and release from the pancreas.

By activating both of these hormones, tirzepatide helps to lower blood sugar levels and improve insulin sensitivity, which can help to control diabetes.

Mounjaro (Tirzepatide) is administered as a subcutaneous injection once a week, and it is important to follow the dosing instructions provided by your healthcare provider. It is also important to continue following a healthy diet and exercise plan while taking tirzepatide to help manage diabetes.